Review of Palliative Radiotherapy in the Management of Advanced Head and Neck Cancer
1 other identifier
observational
100
1 country
1
Brief Summary
To describe the charactersitics of patients with advanced head and neck cancer treated with palliative intent and determine outcome in terms of symptom control and toxicity
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2006
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2006
CompletedFirst Submitted
Initial submission to the registry
January 20, 2006
CompletedFirst Posted
Study publicly available on registry
January 24, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2006
CompletedJanuary 28, 2013
July 1, 2006
January 20, 2006
January 24, 2013
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- squamous cell carcinoma of the head and neck, primary treatment given with palliative intent
You may not qualify if:
- radical treatment, palliative treatment following local recurrence, adenocarcinoma, salivary gland carcinoma or melanoma
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tom Baker Cancer Centre
Calgary, Alberta, T2N 4N2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Harold Lau, MD
Alberta Cancerboard
Study Design
- Study Type
- observational
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 20, 2006
First Posted
January 24, 2006
Study Start
January 1, 2006
Study Completion
June 1, 2006
Last Updated
January 28, 2013
Record last verified: 2006-07